Cannabis Policy Impacts Public Health and Health Equity (2024)

Chapter: Appendix B: Public Meeting Agendas

Previous Chapter: Appendix A: Committee Member and Staff Biosketches
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

Appendix B

Public Meeting Agendas

COMMITTEE ON PUBLIC HEALTH CONSEQUENCES OF CHANGES IN THE CANNABIS POLICY LANDSCAPE

National Academy of Sciences,
2101 Constitution Ave. NW
Washington, DC 20418

MEETING 1

SEPTEMBER 15, 2023
ROOM 250

SESSION I—PUBLIC SESSION

10:00–10:20 Purpose of Open Session and Introduction of Committee Members
Steven M. Teutsch, Committee Chair
10:20–10:45 Centers for Disease Control and Prevention (CDC) Perspectives on Study Scope, Background, and Objectives
Brooke Hoots, Cannabis Strategy Unit Lead, Division of Overdose Prevention, CDC
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
10:45–11:10 National Institute on Drug Abuse (NIDA) Perspectives on Study Scope, Background, and Objectives
Susan Weiss, Director, Division of Extramural Research at NIDA, National Institutes of Health
11:10–11:35 National Cancer Institute (NCI) Perspectives on Study Scope, Background, and Objectives
Joseph T. Ciccolo, Program Director, Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, NCI
11:35–11:45 National Center for Complementary and Integrative Health (NCCIH) Perspectives on Study Scope, Background, and Objectives
David Shurtleff, Deputy Director, Acting Scientific Director, NCCIH
11:45–11:50 Food and Drug Administration (FDA) Perspectives on Study Scope, Background, and Objectives
Patrick Cournoyer, Senior Science Advisor and Food and Drug Administration Lead for Cannabis Products, FDA
11:50–12:15 Committee Discusses the Statement of Task with the Study Sponsors
12:15–1:15 Opportunity for Public Comment on the Committee’s Statement of Task
1:15 Public Session Adjourns

MEETING 2

NOVEMBER 29, 2023

SESSION I—WELCOME AND OPENING

11:00–11:10 Welcome and Opening Remarks from the Chair
Steven M. Teutsch, Committee Chair
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

SESSION II—PUBLIC HEALTH AUTHORITIES OF STATE AND LOCAL GOVERNMENTS

11:10–11:50 Keynote Talk: The Public Health Authorities of State and Local Governments as They Pertain to Cannabis in Light of the Federal Prohibition
Anne Boustead, University of Arizona
11:50–12:00 Discussion with Committee

SESSION III—PUBLIC HEALTH AUTHORITIES OF STATE AND LOCAL GOVERNMENTS

12:00–12:20 State Cannabis Policy Landscape: Effects on Public Health
Beth McGinty, Weill Cornell Medicine
12:20–1:05 State Cannabis Policy Landscape
Gillian Schauer, Cannabis Regulators Association (CANNRA)
1:05–1:50 Panel Discussion: Perspectives from State Health Regulators
Adria Berry, Oklahoma Medical Marijuana Authority
Nicole Elliott, California Department of Cannabis Control
Amy Moore, Missouri Department of Health and Senior Services
Michele Nakata, Hawaii Office of Medical Cannabis Control and Regulation
Will Tilburg, Maryland Cannabis Administration
Beth McGinty, Weill Cornell Medicine
Gillian Schauer, CANNRA
1:50–2:05 Break
2:05–2:25 Local Cannabis Policy Landscape: Across California
Ellicott Matthay, New York University
2:25–2:45 Local Cannabis Policy Landscape: Across Oregon and Washington
Julia Dilley, State of Oregon Public Health Division
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
2:45–3:30 Panel Discussion: Perspectives from Local Health Regulators
Molly Duplechian, City and County of Denver
Al Romero-Gibu, City of Grand Rapids
Kim James, City of Detroit
Sarah Ross Viles, Public Health – Seattle & King County
Mathew Swinburne, The Network for Public Health Law
Ellicott Matthay, New York University
Julia Dilley, State of Oregon Public Health Division

SESSION IV—INDUSTRY APPROACH TO THE WIDE VARIATION IN CANNABIS POLICY

3:30–4:15 How does the cannabis industry approach the wide variation in cannabis policy across local, state, and federal authority?
Jonathan Caulkins, Carnegie Mellon
4:15–5:00 Panel Discussion: A Safe and Sustainable Cannabis Industry
Michael Cooper, National Cannabis Industry Association
Daniel Fabricant, Natural Products Association
Micah Sherman, Raven, National Craft Cannabis Coalition
Ross Gordon, Humboldt County Growers Alliance, National Craft Cannabis Coalition
Carrie A. Harney, US Pharmacopeia
5:00–5:15 Break

SESSION V—PUBLIC COMMENT SESSION

5:15–5:55 Public Comment Session

SESSION VI—CLOSING REMARKS

5:55–6:00 Chair’s Reflection and Preview of Workshop Day 2
Steven M. Teutsch, Committee Chair
6:00 Meeting Day 1 Adjourns
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

NOVEMBER 30, 2023

SESSION VII—WELCOME AND OVERVIEW OF THE WORKSHOP SERIES

11:00–11:10 Welcome and Opening Remarks from the Vice Chair
Yasmin Hurd, Committee Vice Chair

SESSION VIII—OVERVIEW OF INTERNATIONAL CANNABIS POLICY

11:10–11:55 What the United States Can Learn from the Changes in Cannabis Use Across Canada
David Hammond, University of Waterloo
11:55–12:45 Panel Discussion: Perspectives from International Researchers
Hanan Abramovici, Health Canada
Arturo Alvarez Roldan, Universidad de Granada, Spain
Alvaro Castillo-Carniglia, Universidad Mayor, Chile
Wayne Hall, University of Queensland, Australia
Rosario Queirolo, Universidad Católica del Uruguay

SESSION IX—BROADER PERSPECTIVES

12:45–1:35 Protecting Public Health and Social Equity with Legal Cannabis
Kevin Sabet, Smart Approaches to Marijuana
Cat Packer, Drug Policy Alliance
Lynn Silver, Public Health Institute
Peter Grinspoon, Massachusetts General Hospital

SESSION X—CLOSING REMARKS

1:35–1:40 Reflections and Closing Remarks from the Vice Chair
Yasmin Hurd, Committee Vice Chair
1:40 Meeting Adjourns
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

MEETING 3

JANUARY 11, 2024

SESSION I—WELCOME AND OPENING

11:00–11:10 Welcome and Opening Remarks from the Committee Chair
Steven M. Teutsch, Committee Chair

SESSION II—CANNABIS AND CRIMINAL JUSTICE: HAVE CANNABIS POLICY REFORMS LED TO IMPROVEMENTS IN SOCIAL EQUITY?

11:10–11:15 Session Introduction
Doug Berman, Committee Member
11:15–11:35 Association between Cannabis Laws and Cannabis Possession Arrest Rates in the United States
Yuyan Shi, University of California, San Diego
11:35–11:55 Mandated Drug Treatment in the Aftermath of Recreational Cannabis Legalization
Katharine Harris, Rice University
11:55–12:15 The Impact of Recreational Cannabis Legalization on Racial Disparities in Cannabis Arrests
Dale Willits, Washington State University
12:15–1:00 Panel Discussion with Session Presenters
Yuyan Shi, University of California, San Diego
Katharine Harris, Rice University
Dale Willits, Washington State University

SESSION III—CANNABIS POLICY CHANGES: IMPACTS ON THE ILLICIT MARKET

1:00–1:05 Session Introduction
Beau Kilmer, Committee Member
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
1:05–1:25 An Economic Perspective on the Impact of Cannabis Legalization on the Illicit Market
Tiffanie Perrault, McGill University

SESSION IV—CONSEQUENCES OF ENTANGLEMENTS WITH THE CRIMINAL JUSTICE SYSTEM

1:25–1:30 Session Introduction
Nick Zaller, Committee Member
1:30–1:50 Ramifications of a Cannabis-Related Criminal Conviction
Jason Ortiz, Last Prisoner Project
1:50–2:35 Panel Discussion: Perspectives of Those Impacted by the Justice System
Donte West, Last Prisoner Project
Stephanie Shephard, Last Prisoner Project
Kyle Page, Last Prisoner Project
Jason Ortiz, Last Prisoner Project
2:35–2:55 Break

SESSION V—CULTIVATING EQUITY: EMPLOYMENT, TAXATION, AND THE ECONOMIC LANDSCAPE OF CANNABIS REGULATION

2:55–3:00 Session Introduction
Debra Furr-Holden, Committee Member
3:00–3:20 Tax Aspects of Cannabis Policy
Alex Brill, American Enterprise Institute
3:20–3:40 Creating Social Equity Through Cannabis Policy
Shaleen Title, Parabola Center for Law and Policy
3:40–4:25 Panel Discussion: State Government Strategies for Social Justice in Cannabis Legalization
Damian Fagon, New York Office of Cannabis Management
Eugene Hillsman, California Department of Cannabis Control
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

Abigail Vivas, Division of Cannabis Regulation, Missouri Department of Health, and Senior Services
Wesley McWhite, Diversity and Inclusion, New Jersey Cannabis Regulatory Commission
Erin Johnson, Illinois Cannabis Regulation Oversight Office
4:25–5:05 Panel Discussion: Municipal Government Strategies for Social Justice in Cannabis Legalization
Imani Brown, City of Los Angeles, California
Garland Doyle, National Council on Municipal Cannabis and City of Pontiac, Michigan
Al Romero-Gibu, Grand Rapids, Michigan
5:05–5:25 Break

SESSION VI—PUBLIC COMMENT SESSION

5:25–5:55 Public Comment Session
Nick Zaller, Committee Member

SESSION VII—CLOSING REMARKS

5:55–6:00 Chair’s Reflection and Preview of Workshop Day 2
Steven Teutsch, Committee Chair
6:00 Meeting Day 1 Adjourns

JANUARY 12, 2024

SESSION VIII—WELCOME AND OVERVIEW OF THE WORKSHOP SERIES

11:00–11:10 Welcome and Opening Remarks from the Committee Vice Chair
Yasmin Hurd, Committee Vice Chair
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

SESSION IX—CONSEQUENCES OF ENTANGLEMENTS WITH THE CRIMINAL JUSTICE SYSTEM

11:10–11:15 Session Introduction
Donald Vereen, Committee Member
11:15–11:45 Panel Discussion: Perspectives of Those Impacted by the Harms of Cannabis Policy
Juli Shamash, Parent, California
Teresa Fiore, Resident, New York
Steve Glassman, Parent, New Jersey
11:45–12:00 Break

SESSION X—CONSEQUENCES OF ENTANGLEMENTS WITH THE CRIMINAL JUSTICE SYSTEM

12:00–12:05 Session Introduction
Kelly Young-Wolff, Committee Member
12:05–12:25 A Comprehensive Look at Cannabis Use Disorder
Deborah Hasin, Columbia University
12:25–12:45 Not Your Grandmother’s Weed: Adolescent Cannabis Use & Mental Health Concerns
Maria Rahmandar, Lurie Children’s Hospital of Chicago, Northwestern University
12:45–1:05 Multi-Level Associations between Changing Cannabis Laws and Cannabis Use Disorder Treatment
Pia M. Mauro, Columbia University
1:05–1:50 Panel Discussion
Deborah Hasin, Columbia University
Maria Rahmandar, Lurie Children’s Hospital of Chicago, Northwestern University
Pia M. Mauro, Columbia University
Kenneth Finn, Springs Rehabilitation
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.

SESSION XI—STRENGTHENING A HARM REDUCTION APPROACH TO PROTECT THE MOST VULNERABLE POPULATIONS

2:10–2:15 Session Introduction
Dustin T. Duncan, Committee Member
2:15–2:45 Harm Reduction Considerations for Marijuana Use and Policy
Sheila P. Vakharia, Drug Policy Alliance
2:45–3:00 Harm Reduction, Cannabis, and Adolescents
Renee Johnson, Johns Hopkins University
3:00–3:45 Panel Discussion: How Can Harm Reduction Policies be Used to Protect Vulnerable Populations
Christopher Williams, Purchase College
Celestina Barbosa-Leiker, Washington State University
Renee Johnson, Johns Hopkins University
Sheila P. Vakharia, Drug Policy Alliance

SESSION IX—CLOSING REMARKS

3:45–4:00 Vice Chair’s Reflection
Yasmin Hurd, Committee Vice Chair
4:00 Meeting Adjourns
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 253
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 254
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 255
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 256
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 257
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 258
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 259
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 260
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 261
Suggested Citation: "Appendix B: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2024. Cannabis Policy Impacts Public Health and Health Equity. Washington, DC: The National Academies Press. doi: 10.17226/27766.
Page 262
Next Chapter: Appendix C: Data Sources Available for Cannabis Surveillance
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.